Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Exousia Bio (LMMY) Change in Accured Expenses (2023 - 2025)

Lamy (LMMY) has disclosed Change in Accured Expenses for 3 consecutive years, with $178170.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 7724.77% to $178170.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $178246.0 through Nov 2025, up 12461.38% year-over-year, with the annual reading at -$1211.0 for FY2025, 301.5% down from the prior year.
  • Change in Accured Expenses hit $178170.0 in Q4 2025 for Lamy, up from $3564.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $178170.0 in Q4 2025 to a low of -$2769.0 in Q2 2024.
  • Historically, Change in Accured Expenses has averaged $18173.4 across 3 years, with a median of $767.0 in 2023.
  • Biggest five-year swings in Change in Accured Expenses: crashed 553.93% in 2024 and later soared 7724.77% in 2025.
  • Year by year, Change in Accured Expenses stood at $924.0 in 2023, then surged by 146.43% to $2277.0 in 2024, then skyrocketed by 7724.77% to $178170.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for LMMY at $178170.0 in Q4 2025, $3564.0 in Q3 2025, and -$1211.0 in Q2 2025.